Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo. - Shao Z; Lee BJ; Rouleau-Turcotte É; Langelier MF; Lin X; Estes VM; Pascal JM; Zha S (Nucleic acids research, 2020)